Journal of Bacteriology, December 2000, p. 6762-6773, Vol. 182, No. 23
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, Oregon 97201-3098
Received 18 April 2000/Accepted 24 July 2000
| |
ABSTRACT |
|---|
|
|
|---|
Products encoded in the trans-acting factor (TAF) region are necessary for the biosynthesis of anguibactin and for maximal expression of iron transport and biosynthesis genes in the plasmid-encoded iron-scavenging system of Vibrio anguillarum. Here we identify angB, a locus located in the TAF region, which encodes products essential for anguibactin biosynthesis. We demonstrate that a 287-amino-acid polypeptide, encoded by angB and designated AngB, has an isochorismate lyase activity necessary for the synthesis of 2,3-dihydroxybenzoic acid, an anguibactin biosynthesis intermediate. Complementation of various angB mutations provided evidence that an additional, overlapping gene exists at this locus. This second gene, designated angG, also has an essential biosynthetic function. The angG gene directs the expression of three polypeptides when overexpressed in Escherichia coli, all of which are translated in the same frame as AngB. The results of site-directed mutagenesis and in vivo phosphorylation experiments suggest that the carboxy-terminal end of AngB and the AngG polypeptide(s) function as aryl carrier proteins involved in the assembly of the anguibactin molecule. Our results also show that the regulatory functions of the TAF are encoded in a region, TAFr, which is distinct from and independent of the angB and angG genes.
| |
INTRODUCTION |
|---|
|
|
|---|
Bacteria of the genus Vibrio are commonly found as etiologic agents of disease in both humans and animals (1). An important member of this group is Vibrio anguillarum, a marine bacterium which is responsible for both marine and freshwater fish epizootics throughout the world (10, 26). The disease caused by V. anguillarum has remarkable similarities to invasive-septicemic disease in humans, and for that reason the V. anguillarum-host fish system is an ideal paradigm for studying a native eukaryotic host-pathogen interaction leading to disease (9, 15-17, 19).
Iron is an essential element for nearly all microorganisms, yet in
biological fluids it exists only as a complex with iron-binding proteins, making it essentially unavailable (9, 18).
Therefore, invasive microorganisms must have the ability to use
complexed iron in order to grow within their hosts. Highly virulent
strains of the marine pathogen V. anguillarum possesses a
65-kb virulence plasmid encoding an iron-scavenging system which is
essential for virulence in this bacterium (19-21, 54). This
system consists of a low-molecular-weight iron-binding compound,
anguibactin; once secreted, this compound competes for bound iron
within the host fish. The iron-anguibactin complex is then internalized
by an energy-dependent transport system which includes the FatA, -B,
-C, and -D proteins (2-5, 27). The genes encoding proteins involved in the biosynthesis and transport of anguibactin lie on a
25-kb contiguous region of the virulence plasmid. However, to achieve
maximal expression of the system, products from a noncontiguously located region of the plasmid are necessary (48).
This poorly defined region, referred to as the
trans-acting factor (TAF) region, encodes a product(s), TAF,
which acts to increase the transcription of the anguibactin
transport-biosynthesis operon, containing fatDCBAangRT, as
well as to increase dramatically the rate of synthesis of the anguibactin molecule itself (37, 48). It has been suggested that rather than encoding a biosynthesis activity directly, TAF acts as
an indirect regulator of anguibactin biosynthesis gene expression
(37, 48). Further positive regulation of anguibactin biosynthesis and transport gene expression is mediated by the plasmid-encoded AngR (for anguibactin system regulator) protein (22). We were recently able to assign the regulatory
functions of AngR to the amino-terminal end of the AngR protein
(52). Recently, we have shown that AngR, in addition to
being a regulator, possesses sequences indicative of nonribosomal
peptide synthetases, suggesting that it may play a role as an
anguibactin biosynthesis enzyme (25, 28, 39, 42, 52).
Negative iron regulation of this system is mediated by the
chromosomally encoded Fur protein, as well as the Fur-regulated
cis-acting antisense RNA
molecule (11, 12, 29, 36,
44, 51, 53).
We report here the dissection of the TAF into two separable entities: an anguibactin biosynthesis function (TAFb) and a trans-acting regulatory function (TAFr). The TAFb region harbors two overlapping genes, angB and angG. The latter is located within the 3' end of the angB coding region. The AngB protein appears to be bifunctional, with its amino end conferring an isochorismate lyase activity required for the production of 2,3-dihydroxybenzoic acid (DHBA) and its carboxyl end likely serving as an aryl carrier protein functioning in anguibactin assembly. We also demonstrate that the carboxy-terminal end of AngB can be synthesized from the angG gene as an independent polypeptide which, like AngB, also functions as an aryl carrier protein involved in anguibactin assembly.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, plasmids, and media.
V. anguillarum
531A(pJHC1) harbors one plasmid, pJHC1, which is a pJM1-like plasmid
containing the iron transport, siderophore biosynthesis, and TAF genes.
This strain was used because it is recombination proficient, therefore
allowing the placement of mutations directly on the pJHC1 plasmid
(47). Table 1 shows the
strains and plasmids used in this endeavor.
|
Marker exchange-eviction mutagenesis. To introduce mutations into the wild-type pJHC1 plasmid, we used a procedure that was based on a method described by Reid and Collmer (34), employing a suicide vector (pTW-MEV) which contained the R6K origin of replication, the sacB gene, and an ampicillin resistance gene. Mutation-containing suicide plasmids were transferred to V. anguillarum 531A(pJHC1) by conjugation. Plasmid integration was confirmed by restriction endonuclease analysis of purified pJHC1 DNA. Plasmid cointegrates were then plated on TSAS containing 10% sucrose in order to identify individuals that had undergone a second recombination event which led to sacB excision. Some of these sucrose-resistant clones were generated by a resolution event leading to the replacement of the wild-type allele on pJHC1 by the mutant allele. Successful replacement mutants were identified by restriction endonuclease analysis of purified pJHC1 DNA.
To generate the ~20-kb deletion that resulted in plasmid pJHC1
, we
created a plasmid cointegrate which, after the first crossover event,
carried both a kanamycin resistance-encoding fragment, inserted within
open reading frame C (ORF C), and the sacB gene. pJHC1
harbors various repeated insertion sequences, and it was our goal to
generate, via recombination events occurring between these sequences,
large deletions, especially in the TAF region. Since the ORF C
kanamycin resistance-encoding insertion did not affect anguibactin
production, final selection with sucrose was done in the absence of
kanamycin to allow the identification of a broader array of
recombinants. Using this method, we were able to isolate several
pJHC1
-like deletions in multiple independent experiments. By
restriction endonuclease analysis, PCR, and Southern blotting, we
determined that pJHC1
was generated by recombination between two
~1.2-kb repeated sequences designated RS-1 (data not shown).
Recombinant DNA procedures. DNA purification, restriction endonuclease analysis, DNA ligations and transformations, PCRs, and agarose gel electrophoresis were performed according to standard protocols (7, 38). Transfer of DNA to V. anguillarum from E. coli strains was accomplished by conjugation as described previously (48). Automated DNA sequencing, primer synthesis, and protein microsequencing were carried out at the Department of Molecular Microbiology and Immunology Core Facility at Oregon Health Sciences University. DNA and protein sequence analysis were carried out at the National Center for Biotechnology Information, using the BLAST network service, and by using the sequence analysis software package of the University of Wisconsin Genetics Computer Group.
RNase protection assays. RNAs were prepared as follows. An inoculum from an overnight culture was grown in minimal medium (1:100) with the appropriate antibiotics. The inoculated cultures were grown with EDDA supplemented to just below the MIC to achieve similar levels of iron-limiting stress for each strain tested. Total RNA was prepared by the hot-phenol method (50). RNase protections were carried out essentially as described previously (12).
Site-directed mutagenesis. The S248L mutation was generated by site-directed mutagenesis, using a Quickchange site-directed mutagenesis kit (Stratagene) and synthetic mutagenic primers S248LU (5'-CTTGATTTTCCTTGGACTTGATTTGATACGCATAATGACACTACATAGC-3') and S248LD (the reverse complement of S48LU). These mutant primers replace the C at the second position of codon 248 with a T, thereby changing the encoded amino acid from a serine to a leucine. This mutation was introduced into plasmids pTW200 and pTW203, resulting in plasmids pTW200S248L and pTW203S248L, respectively. These mutations were verified by DNA sequence analysis.
Analysis of polypeptides encoded within the angB region. The complete angB ORF was cloned into the inducible overexpression vector pQE60 (Qiagen). In this construct, angB gene expression is placed under the control of the strong T5 phage promoter and a His6 tag is translationally fused to the C-terminal end of the ORF. By inducing the phage promoter and selectively purifying His-tagged polypeptides, it is possible to identify polypeptides whose synthesis is directed from the translational start signal of pQE60 as well as from translational start signals within this ORF, as long as they are translated in the same frame as those originating at the plasmid's translational start signal. His-tagged polypeptides were purified under denaturing conditions in a nickel-nitrilotriacetic acid-agarose column, using the protocol recommended by the supplier (Qiagen). Protein separation was carried out by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (30). The resolving gel was 15.5% acrylamide (30:0.8 acrylamide:bisacrylamide ratio).
Detection of angB-encoded polypeptides in V. anguillarum. To analyze angB-encoded polypeptides in V. anguillarum, a polyclonal antiserum was generated by injecting a New Zealand White rabbit with the His-tagged purified polypeptides produced as described above. The presence of angB-encoded polypeptides in V. anguillarum was assessed by radioimmunoprecipitation. Cultures of V. anguillarum cells were grown from early log phase to stationary phase in CM9 minimal medium under iron-limiting conditions in the presence of TRAN-35S-label (1,089 Ci/mmol, 50 µCi/ml; ICN Biomedicals Inc., Costa Mesa, Calif.). The cells were collected by centrifugation and boiled for 10 min in 25 µl of phosphate-buffered saline containing 2% SDS. The samples were then diluted 40-fold with NET gel buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Nonidet P-40, 0.1% SDS, 1 mM EDTA, 0.25% gelatin) and precleared by centrifugation at 16,000 × g for 10 min. Polyclonal AngB antiserum was then added to the cleared lysates at a 1:200 dilution, and the mixtures were incubated for 2 h at 4°C. The immunocomplex was then captured by adding protein A-agarose (50 µl of packed beads) and gently mixing for 1 h at 4°C. The protein A-antigen-antibody complex was then collected by centrifugation for 1 min at 12,000 × g and washed three times with NET gel buffer. Immunoprecipitated proteins were analyzed by SDS-PAGE and fluorography.
To determine if AngB is phosphopantetheinylated, we grew V. anguillarum cells from early log phase to stationary phase in a low-phosphate minimal medium under iron-limiting conditions in the presence of 32Pi (285 Ci/mg; 500 µCi/ml; ICN Biomedicals Inc.). For this experiment, CM9 medium was modified by replacing phosphate with 100 mM MOPS (morpholinepropanesulfonic acid) as a buffer and KH2PO4 was added as a source of inorganic phosphate at a concentration of 0.3 mM. The labeled cells were processed for immunoprecipitation exactly as described above. Immunoprecipitated 32P-labeled proteins were analyzed by SDS-PAGE and autoradiography.Determination of anguibactin synthesis and utilization and DHBA production. Three methods were used to determine anguibactin synthesis. First, strains were tested for their ability to produce a halo on chrome azurol S (CAS) agar (40). Second, supernatants from iron-limited cultures were tested by anguibactin bioassay as previously described (48). Finally, strains were tested for sensitivity to the iron-chelating compound EDDA via growth assays in liquid medium. In all cases, a decrease in halo production on CAS agar correlated with a decrease in anguibactin level in the bioassay and an increase in sensitivity to EDDA. DHBA was assayed by employing the Arnow reaction (6) calibrated with a DHBA standard. In addition, a bioassay employing specific Salmonella strains that require DHBA to synthesize enterobactin (33) was used to confirm the presence of this catechol. Strains were tested for their ability to utilize anguibactin as previously described (48).
Nucleotide sequence accession number. The TAFb locus nucleotide sequence data reported here have been deposited in the GenBank database under accession no. AF311973.
| |
RESULTS |
|---|
|
|
|---|
Identification of ORFs within the TAF region.
To identify the
gene(s) responsible for the TAF activity, we performed exploratory DNA
sequencing within a 20-kb region of the pJM1 plasmid previously shown
to encode TAF activity (48) and searched for DNA sequences
with putative functions consistent with the TAF activities. Using this
approach, a cluster of five ORFs was identified. Four of the ORFs
showed a high degree of homology to proteins necessary for early steps
in the biosynthesis of the DHBA-containing siderophores enterobactin in
E. coli and vibriobactin in Vibrio cholerae
(31, 41, 55): ORF D (EntD, VibD), ORF B (EntB, VibB), ORF E
(EntE, VibE), and ORF C (EntC, VibC) (Fig.
1). ORF D is homologous to a
5'-end-deleted version of EntD and VibD (the deletion corresponds to
the first 37 amino acids, including the starting methionine) and
therefore is probably nonfunctional. ORF E is homologous to EntE, but a
frameshift mutation approximately in the middle of the gene causes
premature termination of the predicted protein; therefore, this ORF is
also probably nonfunctional. ORF C is also deranged compared to EntC
due to two translational stop signals in the ORF. Figure 1 also shows that an additional ORF, ORF F, found within the cluster shows significant homology to members of a family of ATP-binding proteins which act as a subunit in ATP-binding cassette (ABC) transport systems
(32). The most similar proteins within this family are those
known to function in the import of ferrisiderophores. Therefore ORF B,
with similarity to EntB, and ORF F, with similarity to ATP-binding
proteins found in ABC transporters, were the only two ORFs within this
region that were likely to encode functional proteins. These five ORFs
lie within a 9-kb SalI-BamHI fragment and are
flanked by identical inverted insertion sequence elements that are also
identical to ISV-A2, previously found in another region of the pJM1
plasmid (43). These insertion sequences and the ORFs form a
composite transposon-like structure (Fig. 1B). Figure 1A shows the
pathway for enterobactin biosynthesis in E. coli and a
proposed pathway for anguibactin biosynthesis. Only the AngR,
AngH, and AngT components have been characterized to date (45,
52). Since anguibactin contains a DHBA moiety (4, 14), the predicted function of at least ORF B is consistent with a role in anguibactin biosynthesis. For the sake of
simplicity, we have used the designation TAFb (b = biosynthesis)
for the region containing the ORFs.
|
Generation of a deletion derivative, pJHC1
, lacking the TAFb
region.
To test whether the TAFb region plays any role in
anguibactin biosynthesis, we generated a deletion derivative of pJHC1
that lacked this region. We used pJHC1 instead of pJM1 because of the higher-level anguibactin production phenotype conferred by the former,
which increases the sensitivity of detection of this
siderophore in modified derivatives, and also because of the higher
recombination proficiency of the strain harboring pJHC1
(46, 47, 49). This deletion of an approximately 20-kb
segment was generated by marker exchange-eviction mutagenesis
(34) employing 1.4-kb native repeated sequences other
than the ISV-A2 elements (Fig. 2). These
repeated sequences (RS-1) are missing from the pJM1 plasmid (reference
49 and unpublished data). To generate the
mutation, we used a plasmid carrying the R6K origin of
replication (which is nonfunctional in V. anguillarum), the
sacB gene, and the TAFb region cloned as a 9-kb
SalI-BamHI fragment with a kanamycin resistance-encoding fragment inserted within ORF C. This plasmid was mobilized to strain 531A(pJHC1), and plasmid cointegrates were
identified by their kanamycin resistance. These cointegrates were
then grown in TSAS with 10% sucrose. Since the sacB gene product is lethal in gram-negative bacteria, the only clones that grew
were those that had undergone a second recombination event which
excised sacB. These sucrose-resistant derivatives could have arisen by any of several possible resolution events
involving either recombination between the two TAFb regions flanking
the sacB gene, which can result in replacement of the
wild-type ORF C by the mutated ORF C, or recombination between the two
RS-1 sequences, generating a derivative with a deletion encompassing the region shown in Fig. 2. Final selection with sucrose was done in
the absence of kanamycin to allow the identification of a broader array
of recombinants. We describe in this section a deletion derivative,
designated pJHC1
, generated by recombination between the two RS-1
sequences (Fig. 2). The strain harboring this deletion derivative, 531A(pJHC1
), did not produce anguibactin;
however, it retained the ability to utilize this compound when
supplied exogenously (data not shown). This biosynthesis defect was
partially complemented by the addition of a recombinant plasmid,
pTW100, which contained the TAFb region, while the plasmidless
strain S531A-1 harboring only pTW100 neither produced anguibactin
nor could it utilize it. Analysis of pTW100 deletion derivatives
demonstrated that a fragment containing just ORF B (pTW104) was
sufficient for this complementation. Furthermore, the insertion
of the transcriptional-translational terminator
within ORF B
(pTW105) completely abolished complementation (data not shown).
Taken together with the mutagenesis and complementation data (shown in
subsequent sections), these results demonstrate that this ORF is the
only one encoded within this cluster which is absolutely necessary for
anguibactin biosynthesis, and therefore we assigned it the anguibactin
biosynthesis gene designation, angB.
|
Generation of angB and ORF F mutants by allelic
exchange.
Clearly, angB must be the only gene within
this cluster which is obligatory for the biosynthesis of anguibactin,
although its activity restores only part of the maximum anguibactin
biosynthesis potential. However, in the complementation analysis
described above, we could not ensure that ORF F was properly expressed
from plasmid pTW100. Therefore, ORF F, while not absolutely necessary for the synthesis of anguibactin, could contribute to it. To test this
hypothesis, we generated by marker exchange-eviction mutagenesis an
in-frame deletion that removed approximately 50% of this ORF. An
in-frame deletion mutation was created to ensure that the mutation would not influence the expression of angB, because ORF F is
located upstream of and in the same orientation as angB,
which suggested that a potential transcriptional linkage between these
determinants might exist. The angB gene was also mutated by
marker exchange-eviction mutagenesis, resulting in the insertion of the
transcriptional-translational terminator (23) at the
BglII site within the 5' end of the gene. Of these
mutations, the only modification found to affect anguibactin biosynthesis was the mutation introduced into angB in the
strain designated 531A(pJHC1::
). In this strain,
anguibactin production was completely abolished (see Fig. 4A). A strain
carrying the mutation in ORF F was indistinguishable from the wild type
in its behavior on CAS agar as well as its sensitivity to EDDA and production of anguibactin as measured by bioassay (data not shown). These findings confirm that in the TAFb region the angB gene
is essential for anguibactin biosynthesis, and they demonstrate that ORF F has no function in anguibactin biosynthesis under the conditions tested here.
Genetic and biochemical characterization of the angB
functions.
The angB gene possesses an ORF of 864 bp
encoding a predicted 32.4-kDa protein of 287 amino acids. AngB shows
sequence homology to the EntB protein of E. coli (Fig. 1B),
which is a bifunctional protein necessary for a step in the
biosynthesis of DHBA (B activity), a precursor for enterobactin
biosynthesis and for enterobactin assembly (G activity). In EntB, the
DHBA synthesis activity resides in the N-terminal 187 amino acids of
the protein while the enterobactin assembly activity resides in the
C-terminal portion (residues 188 to 285) of the protein (24,
35). To test for bifunctionality of AngB, we constructed a
clone containing the complete angB gene (pTW200), which
would be expected to impart both B and G activities, and an otherwise
identical clone lacking the final 345 nucleotides (114 amino acids) of
angB (pTW201), which would be expected to possess B activity
and lack G activity (Fig. 3). These
constructs were then tested for their ability to complement the
angB mutant strain 531A(pJHC1::
). This
strain, when carrying the full-length angB gene (pTW200),
showed complete complementation for anguibactin synthesis (Fig.
4A). However, when this strain
carried the deletion derivative pTW201, anguibactin was not produced.
To distinguish potential B activity in these strains, they were also
tested for their ability to produce DHBA under iron-limiting
conditions. Figure 4B shows that the strain carrying pTW201 produced
DHBA despite its inability to produce anguibactin. Therefore, the
upstream region of the angB gene, approximately 75% of the
ORF from the 5' end, is sufficient for the production of DHBA; i.e., it
has B activity. However, it does not confer the ability to produce anguibactin. Therefore, the angB gene, like entB,
must also encode another essential anguibactin biosynthesis activity,
in addition to the B activity, which must act somewhat after B activity
in the anguibactin biosynthesis pathway. Furthermore, when introduced into a plasmidless V. anguillarum strain, S531A-1, pTW201
confers the ability to produce DHBA (Fig. 4B), as it did in the
angB mutant strain, indicating that the EntC-like and
EntA-like activities necessary for DHBA production (Fig. 1) must be
encoded on the V. anguillarum chromosome.
|
|
) is clearly
blocked for transcription (and therefore translation) at the same
BglII site. The ability of each of these mutant strains to
produce anguibactin was tested in the presence of 50 µM DHBA in order
to bypass the need for B activity. Interestingly, these two mutants
behaved very differently when grown in the presence of DHBA (Fig.
5, row 1). Neither of these two mutants
produced anguibactin. However, only in strain 531A(pJHC1::K) could this defect be repaired by the
addition of DHBA. This result further confirms that the angB
locus encodes two functions. Furthermore, it also shows that while
transcription of the gene is necessary for both functions, premature
termination of the AngB polypeptide at the BglII
site affects only the DHBA synthesis activity (B activity), leaving the
G activity intact. Therefore, G activity can exist independently of the
AngB polypeptide. This result is corroborated by the finding
that a clone which contains only the 3' end of angB, and
thus has only G activity (Fig. 3), complements the mutation in strain
531A(pJHC1::
) when DHBA is provided (Fig. 5, row 2),
further indicating that G activity is independent of B activity and is
encoded within the 3' end of the angB locus. Conversely, if
a clone containing the 5' end of the angB gene (pTW201), and
thus providing B activity, is harbored by mutant strain
531A(pJHC1::K), which provides G activity, anguibactin is
produced. However, this does not occur when pTW201 is harbored by
mutant strain 531A(pJHC1::
), which does not possess
either B or G activity (Fig. 5, row 3). In summary, the 5' end of the angB gene is sufficient for B activity while the 3' end of
this gene is sufficient for G activity. Since these two activities are
separable, and G activity can exist as an independent entity, we have
designated the region encoding G activity as the angG gene.
|
G+::K, clearly showing that these proteins are
not degradation products of AngB, and therefore they must be initiated
at the sites deduced from the N-terminal sequence analysis (Fig. 6A).
|
A serine residue located within a domain found on aryl carrier
proteins is essential for anguibactin biosynthesis.
Inspection of
the sequence at the carboxy terminus of the G region in AngB and in the
AngG polypeptides revealed the presence of a domain found in
aryl carrier proteins. In such proteins, this domain undergoes covalent
phosphopantetheinylation prior to attachment of the assembling
siderophore or antibiotic at this site (24). Since in most
of these cases phosphopantetheinylation occurs at a specific serine
residue within this domain, we decided to modify this amino acid to
assess its influence on anguibactin production. By using site-directed
mutagenesis, we generated an S248L mutation (Fig. 6A) in two
plasmids, pTW200 and pTW203, thereby creating plasmids
pTW200S248L and pTW203S248L, respectively. The latter plasmid also
carries a Klenow modification of the BglII site within
angB. Each of these plasmids was conjugated to the 531A(pJHC1::
) strain. Figure
7A shows that the S248L mutation leads to
a complete abolishment of anguibactin production compared to the
isogenic control. Yet DHBA production in this mutant is unaffected,
further demonstrating the separability of the B and G activities
(Fig. 7B). To determine whether G activity alone could be modified by
the S248L mutation, we tested pTW203, which has only a functional
angG gene, and an isogenic plasmid with the S248L mutation,
pTW203S248L. The results, shown in Fig. 7A, demonstrated that the
S248L mutation abolishes anguibactin biosynthesis. Because of the lack
of B activity in these derivatives, DHBA was added in order to measure
G activity in strains 3 and 4 (Fig. 7A). These results indicate that
the serine residue at position 248 is essential for G activity
regardless of whether it comes from the AngB or the AngG protein. It is
therefore likely that AngG and the carboxy terminus of AngB are aryl
carrier proteins that undergo phosphopantetheinylation at S248 in one
of the steps in the anguibactin biosynthesis pathway.
|
Analysis of angB- and angG-encoded
polypeptides in V. anguillarum.
To confirm that the
proteins that we identified genetically in V. anguillarum and biochemically in E. coli are
synthesized in the V. anguillarum cytoplasm, we used a
polyclonal antiserum, raised against purified AngB, AngG1, AngG2,
and AngG3 polypeptides, in a radioimmunoprecipitation assay.
Total proteins from various angB and angG mutants
with and without complementing plasmids were steady-state labeled with
[35S]methionine and then subjected to immunoprecipitation
employing the AngB-AngG antiserum. Figure
8A shows that the AngB-AngG
antiserum recognized a 37-kDa protein in wild-type V. anguillarum, but not in the 531A(pJHC1::
)
and 531A(pJHC1::K) mutants (lanes 1 to 3). This protein
was also present in the 531A(pJHC1::
) strain harboring complementing plasmid pTW200, which encodes both B and G activities (Fig. 8A, lane 4). We also examined the
pJHC1::
-containing strain harboring plasmid pTW201,
which encodes a 3'-end-deleted version of angB with B but
not G activity. A protein of 22.5 kDa (Fig. 8A, lane 5), the expected
molecular mass for a construct with a C-terminal truncation, was
detected in this strain. When the S248L mutant plasmid pTW200S248L was
tested in strain 531A(pJHC1::
), a protein which runs
slightly faster than AngB on SDS-PAGE was detected (33 kDa). Since the
S248L mutation is expected to abolish the putative
phosphopantetheinylation site in AngB and in the AngG
polypeptides, it is possible that the different mobilities of
these two proteins on SDS-PAGE gels reflect the presence or absence of
the phosphopantetheinylate moiety. To test this hypothesis, we
performed a 32Pi labeling experiment in
parallel with the [35S]methionine labeling experiment
described above, with the intent of labeling the phosphate group in the
phosphopantetheinylate moiety of AngB. 32P-labeled proteins
were observed only in the wild type and the complemented mutant
strains, and they were completely absent from mutant derivatives (Fig.
8B), demonstrating that AngB is modified by a phosphate-containing
moiety. The absence of 32P label in the truncated AngB
protein suggests that modification occurs at a site within the
carboxy-terminal end of AngB. Furthermore, the absence of
32P label in the AngBS248L mutant protein demonstrates that
this site is essential for modification and suggests that modification is necessary for G activity.
|
Do angB and angG encode the regulatory
activity attributed to the TAF factor?
The TAF products were
originally described as being essential for maximal production of
anguibactin (48) and for maximal expression of anguibactin
biosynthesis and iron transport genes (13, 37, 48). In
previous sections, we defined a subregion of TAF, designated TAFb, in
which we identified the angB and angG genes,
found to be essential for anguibactin biosynthesis, therefore initiating the molecular dissection of the components of the TAF factor(s). Those results indicated that complementation of strain 531A(pJHC1
) with clones encoding both AngB and AngG
polypeptides restored anguibactin biosynthesis to only about
half of the wild-type level. To understand the basis for this partial
complementation, we examined a series of clones in various mutant
strains. Figure 9A shows the anguibactin
production phenotypes for these strains. Strain
531A(pJHC1::
) does not produce anguibactin. When this mutation is complemented with pTW200, resulting in strain
531A(pJHC1::
/pTW200), anguibactin production is
restored to wild-type levels. However, introduction of the same clone
into the 531A(pJHC1
) strain results in the synthesis of about
half of the wild-type level of anguibactin. These results indicate that
the product(s) of the angB and/or angG gene could
only restore partial anguibactin production when complementing strain
531A(pJHC1
) but resulted in wild-type levels of anguibactin
production if complementing the modification in strain
531A(pJHC1::
). Since the plasmid encoding AngB and
AngG (pTW200) is the same in both cases, it is surmised that this
difference in genotype must be associated with the large deletion in
strain 531A(pJHC1
). The deletion that generated this plasmid
extended beyond the TAFb region (Fig. 2). It is reasonable to assume
that there is another component in the missing region that is important for restoration of maximal anguibactin production. We have originally attributed two functions to the TAF factor, one associated with anguibactin production and the other associated with regulation of the
expression of anguibactin biosynthesis and iron transport genes
(37, 48). It is therefore possible that TAFb, which is
essentially AngB and AngG, is only part of the TAF activity and that
another TAF component, which is absent from pJHC1
, is responsible
for the regulatory phenomenon. This missing TAF regulatory component
could influence anguibactin production via a regulatory effect on the
synthesis of the biosynthetic genes angRT, which are encoded
by the iron transport-biosynthesis operon fatDCBAangRT. To
test this hypothesis, we analyzed the levels of expression of the
polycistronic mRNA encoded by the fatDCBAangRT operon (Fig. 2) utilizing a fatB riboprobe in an RNase protection assay.
The strains were grown under iron-limiting conditions at their MICs for
the iron chelator EDDA. Figure 9B, lane 1, shows the
fatB-specific mRNA levels in the wild-type strain
531A(pJHC1). Lane 2 shows that the level of
fatB-specific mRNA in the 531A(pJHC1::
)
strain is moderately reduced compared to the wild-type level. This is likely due to the loss of anguibactin's contribution to the regulation of the polycistronic mRNA encoded by fatDCBAangRT, a
phenomenon described previously (13). Introduction of a
clone harboring the angB- and angG-encoded
activities (pTW200) into the 531A(pJHC1::
) strain
restored production of anguibactin, and therefore the level of
fatB-specific mRNA was also restored to that of the wild
type. However, the level of fatB-specific mRNA in strain
531A(pJHC1
) was dramatically lower than that in the
531A(pJHC1::
) strain (compare lanes 2 and 4). Since
neither of these strains produces anguibactin, the mRNA levels are not
influenced by anguibactin's contribution to fatB
expression, indicating that a regulatory factor must be absent from the
531A(pJHC1
) strain. Furthermore, when the plasmid harboring
angB and angG was introduced into
531A(pJHC1
), the fatB-specific mRNA levels were only
slightly increased; this minor increase is again presumably due to the
regulatory effect caused by the resumption of anguibactin production.
|
| |
DISCUSSION |
|---|
|
|
|---|
Genes encoding anguibactin biosynthesis and utilization functions lie within several operons which are located on a 25-kb region of the V. anguillarum virulence plasmid (48). However, to achieve maximal expression of this iron-scavenging system, products from a noncontiguous region of the plasmid are required. This region, designated TAF, encodes trans-acting factors which act to increase production of the siderophore anguibactin (48) as well as to enhance the expression of a polycistronic mRNA encoded by ferric anguibactin transport and biosynthesis genes (37).
In this work, we have begun the dissection of the TAF region and have determined that there are at least two components. One, TAFb, is directly associated with anguibactin biosynthesis, while the other, TAFr, plays a regulatory role in the expression of the polycistronic mRNA encoded by fatDCBAangRT. The fact that AngR is not only a regulatory protein itself but also a biosynthetic enzyme, as is AngT (52), suggests that TAFr plays an indirect role in anguibactin biosynthesis via its regulatory effect on the two biosynthesis genes present in the same polycistronic mRNA. Our results support this hypothesis: strains lacking the TAFr region were not fully complemented by TAFb for the expression of the fatDCBAangRT operon or for anguibactin production. However, TAFb clones do fully complement both for expression of the fatDCBAangRT operon and for anguibactin production when the strain harbors TAFr.
In this report, we have focused on the analysis of the TAFb component. Our analysis demonstrated that the TAFb region encodes several ORFs exhibiting high levels of homology to proteins involved in the biosynthesis and utilization of DHBA-containing siderophores, such as vibriobactin (55) and enterobactin (31, 41). Only two ORFs, B and F, were found to have the potential to encode functional proteins. However, we showed by generation of an internal deletion that ORF F is not necessary for anguibactin biosynthesis. Our mutagenesis and complementation experiments also demonstrated that two genes within ORF B, now designated angB and angG, are the only genes within this cluster which are necessary for anguibactin biosynthesis. The TAFb region containing this cluster is flanked by identical and inverted insertion sequence elements, forming a composite transposon-like structure. Similar insertion sequences flank the fatDCBAangRT operon (17, 43). These observations suggest that the V. anguillarum virulence plasmid may have acquired siderophore biosynthesis and utilization genes horizontally via transposition events. Chance and necessity may have prompted the acquisition of a mobile unit carrying angB and angG along with the other genes, even though angB and angG were the only two genes in this cluster needed for anguibactin production. These nonessential genes in the TAFb cluster may have accumulated mutations and become pseudogenes later in the evolution of this system. It is also of interest that the gene organization of the pseudogenes ORF C and ORF E, as well as the angB gene, in the TAFb cluster is identical to that of the chromosomally encoded vibC, vibE, and vibB genes of V. cholerae (55), and this organization is distinct from that of the same genes in E. coli (31, 41). It is tempting to speculate that the TAFb cluster originated in V. cholerae or in an ancestral organism and that it was acquired by the V. anguillarum virulence plasmid through transposition events and horizontal transfer.
Members of Earhardt's laboratory isolated transposon mutations in the
3' end of the entB gene that resulted in truncated EntB proteins with the phenotype EntB+ Ent
,
suggesting that an EntG activity was encoded in the 3' end of the
entB gene. Immunological and in vitro
transcription-translation analysis identified only a protein with
a molecular mass corresponding to that of EntB (41).
Therefore, the experimental evidence gathered using the approaches
described above strongly suggested that EntB is a bifunctional
protein. However, these investigators pointed out that their studies
did not completely eliminate the possibility that a separate EntG
polypeptide exists (41).
Our genetic analysis of the TAFb component angB demonstrated that it is a single ORF encoding two distinct functions that are essential for anguibactin biosynthesis. Either of these two activities, B or G, can function independently of the other: a stop mutation at the BglII site located at 194 bp from the translational start of angB, or a deletion of these first 194 bp, destroys B activity without affecting the G activity. Furthermore, deletions of 345 bp from the 3' end abolish G activity, while B activity is unaffected. The B activity encoded by the angB gene corresponds to a 37-kDa protein. The truncated version generated by the 3'-end deletion, which still possesses B activity, was also identified in V. anguillarum as a protein whose molecular mass corresponds to 172 amino acids. We believe that the B activity is an isochorismate lyase (24, 35) required for the conversion of isochorismate to 2,3-dihydro-2,3-DHBA, not only due to the fact that AngB and EntB exhibit significant homology, but also because deletion mutations in the 5' end of the gene that results in the loss of B activity are rescued by the addition of DHBA. Conversely, strains carrying just the 5' end of angB, possessing B activity but deficient in G activity, secrete DHBA.
Our present genetic evidence indicates that, at least in angB mutant backgrounds, an independent entity with G activity can exist in V. anguillarum, since a strain with a nonpolar mutation in the 5' end of the angB gene exhibits G activity even when this mutation is introduced onto the virulence plasmid by allelic exchange. This activity correlates with the presence of three polypeptides that are encoded in the 3' end of the angB gene and are all translated in the same frame as AngB, as demonstrated by using an E. coli overexpression system and protein microsequencing. Although the genetic evidence for the existence of a separate AngG polypeptide is very strong, we were unable to detect such a protein in any V. anguillarum strain, potentially due to low levels of this protein. Because of this we were unable to determine the biological significance of this protein. Our present efforts are directed at elucidating whether AngB and/or one or all of the smaller polypeptides encode the G activity in wild-type cells by creating silent mutations in the ribosome binding sites for the angG-encoded polypeptides.
Recently, Gehring et al. (24) demonstrated that in the
bifunctional EntB protein the enterobactin assembly activity resides in
the C-terminal portion (residues 188 to 285) and showed that EntB must
have a C-terminal apo-aryl carrier protein domain that undergoes
covalent phosphopantetheinylation, most probably at serine 245, located
in a consensus sequence. Comparison of the carboxy-terminal end of AngB
with the AngG polypeptides and the carboxy-terminal end of EntB
identified a similar domain (FLGLDSI) with a serine residue located at
position 248. In AngB this domain extends from amino acids 243 to 249, and it is also present in the corresponding portions of the AngG
proteins. Our results demonstrated that an S248L mutation results in
the loss of the G activity while conserving the B activity, indicating
that this serine residue is essential for G activity. However, we could
not determine whether the loss of G activity caused by the mutation in
AngB is due to an effect on the AngG polypeptides only or also
in the corresponding sequence in the carboxy-terminal end of AngB. What
is clear is that the same mutation in the nonpolar mutant
B
G+::K, which should only synthesize the
AngG polypeptides, results in the loss of G activity. Since
this mutation was a single nucleotide change resulting in the S248L
mutation, it is likely that the change is occurring only at the protein
level, thus providing further proof of the existence of the AngG
polypeptides in these strains. The results of in vivo
phosphorylation experiments suggest that the carboxy-terminal end of
AngB functions as an aryl carrier protein involved in the assembly of
the anguibactin molecule. Since the S248L mutation abolishes G activity
in a strain that should synthesize only the AngG polypeptides,
it is reasonable to think that the S248 site in AngG is also modified
and that AngG is an aryl carrier protein, although these modified
polypeptides were not detected in V. anguillarum.
Our present efforts are directed to elucidate whether one or all of the smaller polypeptides encode the G activity. We have also identified open reading frames within the TAFr region which might encode the functions responsible for the TAFr activity. Analyses of these will contribute to the understanding of the molecular nature of the TAFr regulatory activity encoded by the V. anguillarum virulence plasmid.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health grant AI19018 from the NIH to J.H.C. T.J.W. was the recipient of an NIH postdoctoral training fellowship.
We gratefully acknowledge Lisa Welch's assistance with antibody production and Paul Shapiro's advice regarding radioimmunoprecipitation experiments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, 3181 Sam Jackson Park Rd., Portland, OR 97201-3098. Phone: (503) 494-7583. Fax: (503) 494-6862. E-mail: crosajor{at}ohsu.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Actis, L. A., M. E. Tolmasky, and J. H. Crosa. 1999. Vibrosis, p. 523-557. In P. T. K. Woo, and D. W. Bruno (ed.), Fish diseases and disorders, vol. 3. Viral, bacterial and fungal infections. CAB International Publishing, Wallingford, United Kingdom. |
| 2. | Actis, L. A., M. E. Tolmasky, L. M. Crosa, and J. H. Crosa. 1995. Characterization and regulation of the expression of FatB, an iron transport protein encoded by the pJM1 virulence plasmid. Mol. Microbiol. 17:197-204[CrossRef][Medline]. |
| 3. |
Actis, L. A.,
M. E. Tolmasky,
D. H. Farrell, and J. H. Crosa.
1988.
Genetic and molecular characterization of essential components of the Vibrio anguillarum plasmid-mediated iron-transport system.
J. Biol. Chem.
263:2853-2860 |
| 4. |
Actis, L. A.,
W. Fish,
J. H. Crosa,
K. Kellerman,
S. R. Ellenberger,
F. M. Hauser, and J. Sanders-Loehr.
1986.
Characterization of anguibactin, a novel siderophore from Vibrio anguillarum 775(pJM1).
J. Bacteriol.
167:57-65 |
| 5. |
Actis, L. A.,
S. Potter, and J. H. Crosa.
1985.
Iron-regulated outer membrane protein OM2 of Vibrio anguillarum is encoded by virulence plasmid pJM1.
J. Bacteriol.
161:736-742 |
| 6. |
Arnow, E. L.
1937.
Colorimetric determination of the components of 2,3-dihydroxy-phenylalanine tyrosine mixtures.
J. Biol. Chem.
118:531-537 |
| 7. |
Birnboim, H. C., and J. Doly.
1979.
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res.
7:1513-1523 |
| 8. | Bolivar, F., R. L. Rodriguez, P. J. Greene, M. C. Betlach, H. L. Heyneker, and H. W. Boyer. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95-113[Medline]. |
| 9. | Bullen, J. J., and E. Griffiths (ed.). 1999. Iron and infection, 2nd ed. John Wiley and Sons Ltd., West Sussex, United Kingdom. |
| 10. | Canestrini, G. 1893. La malattia dominante delle anguille. Atti Ist. Veneto Sci. Lett. Arti Cl. Sci. Mat. Nat. 7:809-814. |
| 11. |
Chai, S.,
T. Welch, and J. H. Crosa.
1998.
Characterization of the interaction between Fur and the iron transport promoter of the virulence plasmid in Vibrio anguillarum.
J. Biol. Chem.
273:33841-33847 |
| 12. | Chen, Q., and J. H. Crosa. 1996. Antisense RNA, Fur, iron, and the regulation of iron transport genes in Vibrio anguillarum. J. Biol. Chem. 271:1885-1891. |
| 13. | Chen, Q., A. M. Wertheimer, M. E. Tolmasky, and J. H. Crosa. 1996. The AngR protein and the siderophore anguibactin positively regulate the expression of iron-transport genes in Vibrio anguillarum. Mol. Microbiol. 22:127-134[CrossRef][Medline]. |
| 14. |
Chen, Q.,
L. A. Actis,
M. E. Tolmasky, and J. H. Crosa.
1994.
Chromosome-mediated 2,3-dihydroxybenzoic acid is a precursor in the biosynthesis of the plasmid-mediated siderophore anguibactin in Vibrio anguillarum.
J. Bacteriol.
176:4226-4234 |
| 15. | Crosa, J. H. 1999. Molecular genetics of iron transport as a component of bacterial virulence, p. 255-288. In J. J. Bullen, and E. Griffiths (ed.), Iron and infection, 2nd ed. John Wiley and Sons Ltd., West Sussex, United Kingdom. |
| 16. | Crosa, J. H. 1997. Signal transduction and transcriptional and posttranscriptional control of iron-regulated genes in bacteria. Microbiol. Mol. Biol. Rev. 61:319-336[Abstract]. |
| 17. |
Crosa, J. H.
1989.
Genetics and molecular biology of siderophore-mediated iron transport in bacteria.
Microbiol. Rev.
53:517-530 |
| 18. | Crosa, J. H. 1984. The relationship of plasmid-mediated iron transport and bacterial virulence. Annu. Rev. Microbiol. 38:69-89[CrossRef][Medline]. |
| 19. | Crosa, J. H. 1980. A plasmid associated with virulence in the marine fish pathogen Vibrio anguillarum specifies an iron-sequestering system. Nature 284:566-568[CrossRef][Medline]. |
| 20. |
Crosa, J. H.,
L. L. Hodges, and M. H. Schiewe.
1980.
Curing of a plasmid is correlated with an attenuation of virulence in the marine fish pathogen Vibrio anguillarum.
Infect. Immun.
27:897-902 |
| 21. | Crosa, J. H., M. H. Schiewe, and S. Falkow. 1997. Evidence for plasmid contribution to the virulence of the fish pathogen Vibrio anguillarum. Infect. Immun. 18:509-513. |
| 22. | Farrell, D. H., P. Mikesell, L. A. Actis, and J. H. Crosa. 1990. A regulatory gene, angR, of the iron uptake system of Vibrio anguillarum: similarity with phage P22 cro and regulation by iron. Gene 86:45-51[CrossRef][Medline]. |
| 23. |
Frey, J., and H. M. Krisch.
1985.
mutagenesis in gram-negative bacteria: a selectable interposon which is strongly polar in a wide range of bacterial species.
Gene
36:143-150[CrossRef][Medline].
|
| 24. | Gehring, A. M., K. A. Bradley, and C. T. Walsh. 1997. Enterobactin biosynthesis in Escherichia coli: isochorismate lyase (EntB) is a bifunctional enzyme that is phosphopantetheinylated by EntD and then acylated by EntE using ATP and 2,3-dihydroxybenzoate. Biochemistry 36:8495-8503[CrossRef][Medline]. |
| 25. |
Guilvout, I.,
O. Mercereau-Puijalon,
S. Bonnefoy,
A. P. Pugsley, and E. Carniel.
1993.
High-molecular-weight protein 2 of Yersinia enterocolitica is homologous to AngR of Vibrio anguillarum and belongs to a family of proteins involved in nonribosomal peptide synthesis.
J. Bacteriol.
175:5488-5504 |
| 26. | Harbell, S. O., H. O. Hodgins, and M. H. Schiewe. 1979. Studies on the pathology of vibriosis in coho salmon. J. Fish Dis. 2:527-535. |
| 27. | Jalal, M., V. Hossain, D. van der Helm, J. Sanders-Loehr, L. A. Actis, and J. H. Crosa. 1989. Structure of anguibactin, a unique plasmid-related bacterial siderophore from the fish pathogen Vibrio anguillarum. J. Am. Chem. Soc. 111:292-296[CrossRef]. |
| 28. | Konz, D., A. Klens, K. Schorgendorfer, and M. A. Marahiel. 1997. The bacitracin biosynthesis operon of Bacillus licheniformis ATCC 10176: molecular characterization of three multi-modular synthetases. Chem. Biol. 4:927-937[CrossRef][Medline]. |
| 29. |
Köster, W. L.,
L. A. Actis,
L. S. Waldbeser,
M. E. Tolmasky, and J. H. Crosa.
1991.
Molecular characterization of the iron transport system mediated by the pJM1 plasmid in Vibrio anguillarum.
J. Biol. Chem.
266:23829-23833 |
| 30. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef] |